Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques
Viruses · 2026
DOI: 10.3390/v18101133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Jian Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of California Los Angeles (UCLA) AIDS Institute, Los Angeles, CA 90024, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Hematopoietic Stem Cells, HIV-1, HIV Infections. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Washington National Biomedical Research Center, Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium, James B. Pendleton Charitable Trust.
Abstract (Originalsprache)
Despite significant medical progress, HIV-1 remains a critical global health crisis. While combination antiretroviral therapy (cART) effectively suppresses viremia, it is not curative due to the persistence of latent viral reservoirs. Autologous hematopoietic stem and progenitor cell (HSPC) gene therapy offers a promising avenue toward sustained, drug-free remission. In this study, we investigated the feasibility and safety of a multifunctional “defend and attack” HSPC gene therapy strategy in the pigtail macaque (Macaca nemestrina) model. The species-optimized lentiviral vector, PM-MNDU-anti-HIV-1-huEGFRt, carries four therapeutic payloads: a pigtail macaque-specific CCR5 shRNA (PM-CCR5sh1005), a CD4-based chimeric antigen receptor (D1D2CAR), a C46 fusion inhibitor peptide, and a truncated human epidermal growth factor receptor (huEGFRt) serving as a cell-surface tracking marker and anti-EGFR antibody Cetuximab (CTX)-mediated negative selection marker. Following busulfan conditioning, autologous transplantation of vector-modified HSPCs in two pigtail macaques resulted in safe hematopoietic recovery. Both animals achieved sustained, multilineage gene marking in peripheral blood and lymphoid tissues without adverse effects. In one animal, upon Simian–Human Immunodeficiency Virus (SHIV) challenge, vector-modified cells underwent robust, antigen-driven multilineage expansion across both lymphoid and myeloid compartments, which contracted during cART-induced viral suppression and rapidly rebounded following treatment interruption. Administration of CTX demonstrated partial, transient reduction in huEGFRt+ cells, accompanied with a reciprocal increase in plasma viral load. These findings support the feasibility of evaluating a multi-pronged anti-HIV HSPC gene therapy strategy with a negative selection marker in a non-human primate (NHP) model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of California Los Angeles (UCLA) AIDS Institute, Los Angeles, CA 90024, USA.
- UCLA Joe C. Wen School of Nursing, UCLA, Los Angeles, CA 90095, USA.
- Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
- Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA 90095, USA.
- Department of Medicine, University of Washington, Seattle, WA 98195, USA.
ORCID-Profile: Jason Murray, Teresa Einhaus, Stefan Radtke, Dong Sung An
Förderung
- Washington National Biomedical Research Center
- Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium
- James B. Pendleton Charitable Trust
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIAID NIH HHS
- McCarthy Family Foundation
- NIDDK NIH HHS
Zitieren
APA
Zhang, J., Murray, J., Mu, W., Venugopal, S., Yim, E., Einhaus, T., Radtke, S., Peterson, C. W., Kiem, H. P., & An, D. S. (2026). Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques. Viruses. https://doi.org/10.3390/v18101133
Vancouver
Zhang J, Murray J, Mu W, Venugopal S, Yim E, Einhaus T, et al. Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques. Viruses. 2026. doi:10.3390/v18101133
BibTeX
@article{Zhang2026,
author = {Zhang, Jian and Murray, Jason and Mu, Wenli and Venugopal, Surya and Yim, Ella and Einhaus, Teresa and Radtke, Stefan and Peterson, Christopher W and Kiem, Hans-Peter and An, Dong Sung},
title = {Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18101133}
}
EUVIMED